| Patents for A61P 37 - Drugs for immunological or allergic disorders (117,141) |
|---|
| 07/13/1999 | US5922595 Cyclic GMP phosphodiesterase |
| 07/13/1999 | US5922571 Polynucleotides encoding a protein kinase C homolog |
| 07/13/1999 | US5922562 Nucleic acids encoding transferrin receptors |
| 07/13/1999 | US5922546 Human disintegrin metalloprotease KUZ gene |
| 07/13/1999 | US5922323 Transferrin receptor genes and immunogenic compositions derived therefrom |
| 07/13/1999 | US5922320 Recombinant proCVF |
| 07/13/1999 | US5922319 Methods of treating eye conditions with human leukocyte elastase (HLE) inhibitory agents |
| 07/13/1999 | US5922318 Drug protein |
| 07/13/1999 | CA2044154C Method of assaying d-vanillylmandelic acid, and reagent and kit therefor |
| 07/13/1999 | CA2033044C 6-substituted purine carbocyclic nucleosides |
| 07/08/1999 | WO1999034007A1 Delivery of polypeptide-encoding plasmid dna into the cytosol of macrophages by attenuated suicide bacteria |
| 07/08/1999 | WO1999033989A2 Rantes mutants and therapeutic applications thereof |
| 07/08/1999 | WO1999033981A2 Human signal peptide-containing proteins |
| 07/08/1999 | WO1999033873A1 NOVEL POLYPEPTIDES, cDNAS ENCODING THE SAME AND UTILIZATION THEREOF |
| 07/08/1999 | WO1999033868A2 Human papillomavirus vaccine |
| 07/08/1999 | WO1999033827A1 Novel imidazole derivatives |
| 07/08/1999 | WO1999033822A1 Indole derivatives useful a.o. for the treatment of osteoporosis |
| 07/08/1999 | WO1999033806A1 4-[aryl(piperidin-4-yl)] aminobenzamides which bind to the delta-opioid receptor |
| 07/08/1999 | WO1999033799A1 Gamma-glutamyl and beta-aspartyl containing immunomodulator compounds and methods therewith |
| 07/08/1999 | WO1999033793A2 Prodrugs of aspartyl protease inhibitors |
| 07/08/1999 | WO1999033488A2 Adjuvanted vaccine formulation |
| 07/08/1999 | WO1999033479A1 Use of parasitic biological agents for prevention and control of autoimmune diseases |
| 07/08/1999 | WO1999033355A2 Fat blend |
| 07/08/1999 | WO1999011275A9 Use of immunostimulatory oligonucleotides for preventing or reducing antigen-stimulated, granulocyte-mediated inflammation |
| 07/08/1999 | WO1999004810A3 Use of mhc class ii ligands as adjuvant for vaccination and of lag-3 in cancer treatment |
| 07/08/1999 | WO1998045711A3 Assay for ligands to tyrosine kinase receptors |
| 07/08/1999 | CA2317111A1 Delivery of polypeptide-encoding plasmid dna into the cytosol of macrophages by attenuated suicide bacteria |
| 07/08/1999 | CA2316341A1 4-[aryl(piperidin-4-yl)] aminobenzamides which bind to the delta-opioid receptor |
| 07/08/1999 | CA2316218A1 Prodrugs of aspartyl protease inhibitors |
| 07/08/1999 | CA2315790A1 Use of parasitic biological agents for prevention and control of autoimmune diseases |
| 07/08/1999 | CA2315723A1 Indole derivatives useful a.o. for the treatment of osteoporosis |
| 07/08/1999 | CA2315617A1 Human signal peptide-containing proteins |
| 07/08/1999 | CA2315276A1 Human papillomavirus vaccine |
| 07/07/1999 | EP0927758A2 Recombinant antibodies specific for TNF-Alpha |
| 07/07/1999 | EP0927254A1 Antagonists of interleukin-15 |
| 07/07/1999 | EP0927252A1 Antibodies against interferon alpha/beta receptor |
| 07/07/1999 | EP0927192A1 Modified aminoacids, pharmaceuticals containing these compounds and method for their production |
| 07/07/1999 | EP0927191A2 Anti-inflammatory peptides and uses thereof |
| 07/07/1999 | EP0927183A1 Spirocyclic metalloprotease inhibitors |
| 07/07/1999 | EP0927182A2 Alkylated rapamycin derivatives |
| 07/07/1999 | EP0927170A1 Piperazino derivatives as neurokinin antagonists |
| 07/07/1999 | EP0927167A1 2-phenyl benzimidazole derivatives as mcp-1 antagonists |
| 07/07/1999 | EP0927156A1 Biphenyl butyric acids and their derivatives as inhibitors of matrix metalloproteinases |
| 07/07/1999 | EP0661985B1 Peptides capable of binding cd8 molecules on ctl precursors |
| 07/07/1999 | EP0609437B1 Novel sphingoglycolipid and use thereof |
| 07/07/1999 | EP0502188B1 Cloned glutamic acid decarboxylase |
| 07/07/1999 | CN1222160A Pregnane derivatives with no alpha-17 substitutent, their medicinal use, mfg. method and its intermediaries and related compounds |
| 07/07/1999 | CN1221608A Synergistic combination of AIDS antiviral compounds and HIV inhibitor |
| 07/07/1999 | CN1043997C 2,6-diaminopurine derivatives, its use and medicinal compsns. containing same |
| 07/06/1999 | US5919943 Inhibition of spla2 |
| 07/06/1999 | US5919904 Response regulator polypeptides; screening for bactericides |
| 07/06/1999 | US5919903 Low affinity human IL-12 beta2 receptor |
| 07/06/1999 | US5919818 Tocotrienols and tocotrienol-like compounds and methods for their use |
| 07/06/1999 | US5919810 1H-indole-3-glyoxylamide sPLA2 inhibitors |
| 07/06/1999 | US5919789 Xanthines and their therapeutic use |
| 07/06/1999 | US5919779 5,6-Heteroaryl-dipyrido(2,3-B:3', 2'-F) azepines and their use in the prevention or treatment of HIV infection |
| 07/06/1999 | US5919664 For screening for antibacterial compounds |
| 07/06/1999 | US5919660 Human requiem |
| 07/06/1999 | US5919637 Method for identifying reduced binding between GMP-140 and GMP-140 ligand |
| 07/06/1999 | US5919463 Inducing immune response in mammals |
| 07/06/1999 | US5919453 Monoclonal antibodies against the interferon receptor, with neutralizing activity against type I interferon |
| 07/06/1999 | US5918452 Foldable, pull-type, V-rake apparatus |
| 07/01/1999 | WO1999032637A1 Human signal transduction serine/threonine kinase |
| 07/01/1999 | WO1999032634A2 Compositions derived from mycobacterium vaccae and methods for their use |
| 07/01/1999 | WO1999032610A1 Human nucleotide pyrophosphohydrolase-2 |
| 07/01/1999 | WO1999032483A1 New pharmaceutically active compounds |
| 07/01/1999 | WO1999032456A1 Phthalazine derivatives phosphodiesterase 4 inhibitors |
| 07/01/1999 | WO1999032451A1 Azepine or larger medium ring derivatives and their use as pharmaceuticals |
| 07/01/1999 | WO1999032449A2 Benzazine derivatives as phosphodiesterase 4 inhibitors |
| 07/01/1999 | WO1999032148A1 Methods and compositions for inhibiting tumor cell growth |
| 07/01/1999 | WO1999032141A1 Ifnar2/ifn complex |
| 07/01/1999 | WO1999032138A1 Method for reducing susceptibility to hiv infection |
| 07/01/1999 | WO1999032125A1 Composition for treating respiratory and skin diseases, comprising at least one leukotriene antagonist and at least one antihistamine |
| 07/01/1999 | WO1999032111A1 INHIBITION OF p38 KINASE ACTIVITY USING SUBSTITUTED HETEROCYCLIC UREAS |
| 07/01/1999 | WO1999032089A1 Pharmaceutical compositions comprising micelles comprising lipophilic glucocorticosteroid and only one surfactant |
| 07/01/1999 | WO1999025832A8 Toso |
| 07/01/1999 | WO1999018801A9 Methods and compositions for the treatment of autoimmune disease using heat shock proteins |
| 07/01/1999 | WO1999010014A3 Receptor-mediated gene delivery using bacteriophage vectors |
| 07/01/1999 | DE19757414A1 Fettmischung Fatblend |
| 07/01/1999 | DE19756261A1 Neue arylsubstituierte Pyridylalkan-, alken- und alkincarbonsäureamide New pyridylalkane aryl, alkene and alkincarbonsäureamide |
| 07/01/1999 | DE19756236A1 Neue piperazinylsubstituierte Pyridylalkan-, alken- und -alkincarbonsäureamide New piperazinyl substituted pyridylalkane, alkene and -alkincarbonsäureamide |
| 07/01/1999 | DE19756235A1 Neue piperidinylsubstituierte Pyridylalkan- alken- und -alkincarbonsäureamide New piperidinylsubstituierte pyridylalkane alkene and -alkincarbonsäureamide |
| 07/01/1999 | DE19756212A1 Neue, mit einem cyclischen Imid substituierte Pyridylalkan-, alken- und -alkincarbonsäureamide Novel substituted with a cyclic imide pyridylalkane, alkene and -alkincarbonsäureamide |
| 07/01/1999 | CA2315788A1 Human nucleotide pyrophosphohydrolase-2 |
| 07/01/1999 | CA2315782A1 Pharmaceutical compositions comprising micelles comprising lipophilic glucocorticosteroid and only one surfactant |
| 07/01/1999 | CA2315720A1 Inhibition of p38 kinase activity using substituted heterocyclic ureas |
| 07/01/1999 | CA2315539A1 Compositions derived from mycobacterium vaccae and methods for their use |
| 07/01/1999 | CA2315037A1 Methods and compositions for inhibiting tumor cell growth |
| 07/01/1999 | CA2313805A1 Method for reducing susceptibility to hiv infection |
| 06/30/1999 | EP0926237A2 Nucleic acid constructs for gene therapy, whose activity is influenced by inhibitors of cyclin-dependent kinases |
| 06/30/1999 | EP0926236A1 Binding partners for inhibitors of cyclin-dependent kinases and their use for inhibitor screening, diagnosis or therapy |
| 06/30/1999 | EP0926138A1 Diamide compounds and drugs containing the same |
| 06/30/1999 | EP0925356A1 New antigen presenting cells, a process for preparing the same and their use as cellular vaccines |
| 06/30/1999 | EP0925307A1 Enzyme and dna sequence encoding same |
| 06/30/1999 | EP0925303A1 Phosphinic acid amides as matrix metalloprotease inhibitors |
| 06/30/1999 | EP0925299A1 Pyrazolopyridine compound and pharmaceutical use thereof |
| 06/30/1999 | EP0925298A1 Substituted 6,6-hetero-bicyclic derivatives |
| 06/30/1999 | EP0925296A1 New pharmaceutically active compounds |
| 06/30/1999 | EP0925294A1 Substituted 2(2,6-dioxopiperidin-3-yl)phthalimides and -1-oxoisoindolines and method of reducing tnf-alpha levels |
| 06/30/1999 | EP0925287A1 Heterocyclic metalloprotease inhibitors |